Ann: Response to ASX query, page-5

'This year, SRX’s 6-monthly planning processes were completed on 5th December. The next board meeting was on 6th December 2016. At that meeting, the CEO tabled, and spoke to, a paper which included a revised estimate of dose sales growth for FY17. The paper was discussed by the board, but no revised estimate was adopted or approved by the board at that meeting. Further work on the revised estimate was required by the board. '

And when did a large fund dump think end of 1m shares?

Loose lips sink ships, as Mr Churchill said.